Skip to main content
Premium Trial:

Request an Annual Quote

Steven Beasley, Steve Kushman, Mark Atlas, Andrey Zarur, John Steuart

Gentronix last week said it had appointed Steven Beasley as commercial director and member of the board.
Beasley will head the commercial operations of Gentronix as it moves forward with its growth plans for GreenScreen HC and its next-generation products. He was previously CEO of bioKneX and chief business officer of De Novo Pharmaceuticals.

Fluxion said last week that it has hired Steve Kushman as manufacturing director and Mark Atlas as sales director. The company also announced that Andrey Zarur, a general partner of Kodiak Venture Partners, and John Steuart, a co-founder and managing director of Claremont Creek Ventures, will join its board of directors (see story, this issue).

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.